Spisulosine
| Catalog Number | BL-M000971 |
| CAS Number | 196497-48-0 |
| Description | Spisulosine, also known as ES-285, is novel compound derived from the marine mollusk Spisula polynoma with evidence of preclinical antitumor activity. Phase I clinical trial results: Dose level VIII (200 mg/m(2)) was considered the MTD, and dose level IX (160 mg/m(2)) was defined as the RD. Limited antitumor activity was observed. |
 | |
| IUPAC Name | (2S,3R)-2-aminooctadecan-3-ol |
| Synonyms | 1-deoxysphinganine (m18:0); ES-285; ES 285; ES285; 1-deoxy SA; (2S,3R)-2-amino-3-hydroxy-octadecane; (+)-Spisulosine; 3-Octadecanol, 2-amino-, (R-(R*,S*))-; (2S,3R)-2-amino-3-octadecanol; 2S-amino-3R-octadecanol |
| Molecular Weight | 285.51 |
| Molecular Formula | C18H39NO |
| Boiling Point | 405.3±18.0°C (Predicted) |
| Melting Point | 115-116°C |
| Purity | >99% |
| Density | 0.871±0.06 g/cm3 (Predicted) |
| Solubility | Soluble in DMF (10 mg/mL), DMSO (2 mg/mL), Ethanol (miscible) |
| Appearance | Crystalline Solid |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 75.72%, H 13.77%, N 4.91%, O 5.60 |
| Canonical SMILES | CCCCCCCCCCCCCCCC(C(C)N)O |
| InChI | InChI=1S/C18H39NO/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18(20)17(2)19/h17-18,20H,3-16,19H2,1-2H3/t17-,18+/m0/s1 |
| InChI Key | YRYJJIXWWQLGGV-ZWKOTPCHSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
